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Abstract
Randomized trials for selective and indicated prevention of depression
in both mixed-aged and older adult samples, conducted in high-income
countries (HICs), show that rates of incident depression can be reduced
by 20–25% over 1–2 years through the use of psychoeducational and
psychological interventions designed to increase protective factors. Re-
currence of major depression can also be substantially reduced through
both psychological and psychopharmacological strategies. Additional
research is needed, however, to address the speciﬁc issues of depres-
sion prevention in older adults in low- and middle-income countries
(LMICs). The growing number of older adults globally, as well as work-
force issues and the expense of interventions, makes it important to
develop rational, targeted, and cost-effective risk-reduction strategies.
In our opinion, one strategy to address these issues entails the use of
lay health counselors (LHCs), a form of task shifting already shown to
be effective in the treatment of common mental disorders in LMICs.
We suggest in this review that the time is right for research into the
translation of depression-prevention strategies for use in LMICs.
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LMICs: low- and
middle-income
countries
HICs: high-income
countries
Indicated
prevention:
intervening to prevent
major depression in a
person who already has
mild, or subthreshold
(i.e., subsyndromal)
symptoms
LHCs: lay health
counselors
INTRODUCTION
In this review, we set forth a case for the public
health signiﬁcance of preventing major depres-
sive episodes in older adults, particularly given
the demographic shifts taking place in low- and
middle-income countries (LMICs) as well as in
high-income countries (HICs). Our literature
review of studies conducted in HICs indicates
that a reasonably robust evidence base exists for
selective and indicated prevention of late-life
depression. More recent information from
studies in LMICs has shown that lay health
counselors (LHCs) can effectively deliver
psychosocial interventions in a collaborative,
stepped-care framework to treat prevalent
cases of common mental disorders (33, 34).
Thus, the stage is set for translating depression-
prevention strategies to LMICs through lay
delivery systems. Here we set forth the ob-
jectives of depression prevention, summarize
approaches that are promising in 2012, and
make recommendations for future depression-
prevention research in both HICs and LMICs.
WHY IS PREVENTION OF MAJOR
DEPRESSION IMPORTANT,
ESPECIALLY IN OLDER ADULTS?
From a public health perspective, prevention
of major depression in later life is important for
the following reasons (24, 34): First, depressive
episodes in older adults are prevalent and
disabling (6–10% in primary-care settings,
30% in medical and long-term care settings);
second, depression is associated with signiﬁcant
excess mortality after myocardial infarction and
stroke as well as for cancer, and it is the major
risk factor for suicide in old age; third, available
treatments are∼50% effective in achieving and
sustaining remission and health-related quality
of life, and in averting years livedwith disability;
fourth, milder or subthreshold (subsyndromal)
states increase the risk of developing the full
clinical disorder but may be more reversible
than the advanced clinical state and may also
be associated with neurobiological changes
at an earlier and more modiﬁable stage of
development; ﬁfth, the geriatric mental health
workforce shortages confronting the world
also drive the imperative for devising effective,
scalable, depression-prevention models that
can be implemented by general medical coun-
selors or LHCs (34) rather than mental health
specialty clinicians (26); and ﬁnally, preventing
depression in older adults may be cost-effective
(51).
Two questions provide the organizing
framework for depression-prevention research
and practice in older adults: Can early, targeted
intervention reduce incidence, severity, or du-
ration of incident major depressive episodes to
a clinically signiﬁcant degree among older in-
dividuals at increased risk for or already living
with subthreshold symptoms of depression, and
how do we best organize and implement in-
terventions to prevent major depression in a
community-dwelling elderly population?
The goals of research and practice are to im-
prove accuracy in predicting major depression
in older adults and their caregivers, to guide
the timely introductionof risk-reduction strate-
gies, and to determine any additional health and
economic beneﬁts to prevention of major de-
pression in older adults. These could include
slower progression of cognitive decline, better
control of pain, enhanced cardiovascular and
cerebrovascular health, less caregiver burden,
and lower cost to the health care delivery sys-
tem. All these are signiﬁcant downstream bur-
dens that could be mitigated through preven-
tion of depression in later life.
In addition, however, basic research into the
biological and psychosocial processes leading to
depression could also help by discovering new
possibilities to prevent depression. A heuristi-
cally useful example is provided by studies of
the pathogenesis of depression in patients ex-
posed to interferon alpha (IFA) for treatment of
hepatitis C (29). In such patients, sleep distur-
bance may increase IFA’s depressogenic effects
whereas, conversely, improving sleep quality
could protect from the development of depres-
sion. In a similar vein, more research is needed
on the causes of social inequalities in the in-
cidence and prevalence of depression and the
124 Reynolds et al.
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variable distribution of these factors across dif-
ferent societies (1, 8).
By preventing depression in older adults,
one aims to prevent a downward spiral of
depression → disability → death, that is, to
enhance and prolong older adults’ capacity
for independence and improve their quality
of life. Because depression diminishes both
functional ability and life span, the ultimate
goal of depression prevention is to protect and
increase both (24, 36).
The doubling of the number of older adults
living with a mental disorder by 2030 is only
part of the public health challenge of, and ra-
tionale for, preventing episodes of major de-
pression in old age. Speciﬁcally, older adults of
low socioeconomic status have elevated risk for
chronic illnesses, including depression. The so-
cial worlds that put older adults at risk for de-
pression, especially those living in low-income
neighborhoods, also act to reduce the effective-
ness of antidepressant treatment (13). Thus, re-
search and practice in depression prevention
must also involve socially disadvantaged adults
(who are often racial and ethnicminorities). For
example, at Pittsburgh, we are currently con-
ducting a randomized controlled trial (RCT) of
prevention via problem-solving therapy (PST)
to prevent episodes ofmajor depression, dimin-
ish disability, and improve health-related qual-
ity of life in low-income adults (35% of whom
are African Americans) who have risk factors
for depression and are already mildly symp-
tomatic (48). The control condition is health
education in dietary practices, chosen because
of the high rate of obesity among participants
and the need to provide an attentional control.
Relative to white participants in the trial, black
participants have (a) lower household income
and formal years of education, (b) higher rates of
major health hazards (obesity, diabetes, hyper-
tension), (c) higher rates of physical disability,
and (d ) more frequent histories of alcohol or
substance abuse (49). About one-third of both
blacks and whites report a remote prior history
ofmajor depressive episodes. Subjects are being
followed for two years, with booster sessions of
PST or of health education every six months.
PST: problem-solving
therapy
Selective prevention:
intervening to prevent
major depression in a
person who has risk
factors for depression
but is not yet
symptomatic
As we review below, the successful conduct of
depression-prevention research requires an in-
frastructure of community partnerships with
primary-care and social service agencies that
reach the vulnerable populations most in need
of preventive interventions. Additional adapta-
tion to the language, culture, and conditions of
LMICswill benecessary to advancedepression-
prevention research and to have an impact on
the global burden of depression’s illness-related
disability. In return, demonstrating the efﬁcacy
of a low-cost, task-shifting approach to pre-
vention of depression is relevant to the United
States, especially in regions that are in short
supply of mental health resources of any kind.
WHAT ARE THE OBJECTIVES OF
DEPRESSION PREVENTION?
Implicit in the discussion of depression preven-
tion in older adults are three underlying objec-
tives: the preemption of incident episodes of de-
pression; the prevention of recurrent episodes
of depression; and ﬁnally, the protection from
depression’s medical and psychosocial compli-
cations (24, 36).
The Institute ofMedicine (IOM) delineated
several types of depression prevention in its
1994 (25) and 2009 (27) reports: universal, se-
lective, and indicated prevention. In univer-
sal prevention, the entire population base, re-
gardless of whether all individuals in it are at
risk for depression, is targeted. An example
would be outreach through media to promote
protective factors and well-being through ex-
ercise and healthy sleep and dietary practices
and to educate the general population about
the early warning signs of depression, to dis-
pel stigma about depression, and to encourage
help-seeking; educational outreach to primary-
care physicians, to educate them about the risk
factors (such as depression) for suicide in older
adults, is another example.
As opposed to this wide-scale intervention,
selective prevention focuses on those patients
presenting with established susceptibility on
the basis of a set of risk factors. For exam-
ple, in the case of late-life depression, such
www.annualreviews.org • Early Intervention to Reduce Depression 125
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NNT: number
needed to treat
well-known risk factors include disability, social
isolation, bereavement, and chronic insomnia
(43, 46). Moving toward greater severity of
risk are preventive measures directed toward
patients already living with some symptoms of
depression, though remaining subsyndromal:
so-called indicatedprevention (34, 36).Todate,
most of the published data derive from studies
of selective and indicated prevention. The sam-
ple size requirements for studies of universal
prevention are substantially greater than the
samples of 150–300 generally seen in studies
of selective and indicated prevention (16–18);
thus, this formof large-scale depressionpreven-
tion research has been very hard to implement
both because of the large sample sizes required
and the availability of practicable, easily admin-
istered interventions. Recently, however, the
National Institute ofMental Health has funded
the VITAL-DEP study of universal depression
prevention; VITAL-DEP is an ancillary study
of the efﬁcacy of vitamin D and of ﬁsh oils in
preventing cancer and cardiovascular disease.
VITAL-DEP is described below.
Prevention of depressive disorders is of great
public health signiﬁcance not only in HICs but
also in LMICs.The speciﬁc concerns regarding
late-life depression in LMICs include the rapid
demographic transition and aging in countries
such as China and India; changing social con-
ditions that are recognized as risk factors (e.g.,
living alone or living with a chronic disabling
condition); and the weak response of the health
system to addressing the needs of the elderly
(let alone mental health needs), in particular
the lack of specialist human resources. Inter-
ventions are needed that focus on prevention
that can be delivered by nonspecialist and lay
workers in nonhealth care, home, or primary-
care settings (3, 20, 34, 35).
WHAT ARE PROMISING
APPROACHES FOR 2012?
Both randomized prevention trials and epi-
demiological modeling suggest that prevention
of major depression in later life may be
most efﬁciently accomplished by targeting
elderly persons who experience risk factors,
particularly functional limitations as a result of
illnesses such as stroke or macular degenera-
tion, have a small social network, and/or have
subthreshold (i.e., subsyndromal) symptoms
(41, 42, 46). Efﬁciency of interventions to pre-
vent depression encompasses both the impact
of the intervention and the effort required to
implement it. Impact is reﬂected in the pro-
portion of cases that would be prevented if the
adverse effects of the targeted risk factor were
completely blocked (attributable fraction). Ef-
fort is reﬂected by the number of persons who
would need to receive a depression-prevention
intervention to avoid one new case of late-life
depression (number needed to treat, or NNT).
Schoevers et al. (43) have estimated that the risk
factor where preventive interventions would
have the highest impact and lowest effort is the
presence of subthreshold depressive symptoms
(NNT = 3–4 in indicated prevention versus
NNTs of 7–9 in selective prevention). That is,
preventive interventionsmay havemore impact
in older adults with subthreshold symptoms
(indicated prevention) than in patients without
such symptoms, even though they may have
other risk factors such as disabilities from
medical illness (selective prevention).
Capturing the state of the ﬁeld, a meta-
analytic review of 19 early-intervention trials
with mixed-aged samples reported a pooled in-
cidence rate ratio of 0.78 [95% CI (conﬁdence
interval): 0.65–0.93], indicating a reduction in
incidence of diagnosable major depression of
nearly 20% over 1 year (19). Several published
papers support the efﬁcacy of selective and
indicated prevention of depression in either
at-risk or already mildly symptomatic older
subjects. Some of the studies have used as their
primary outcome variable the occurrence of
major depressive episodes (typically studies of
indicated prevention), whereas other studies
have encompassed both major and minor
depressive episodes as their primary outcome
(typically studies of selective prevention). We
now present examples of each below.
A study exemplifying selective prevention
enrolled patients with recent stroke (41).
126 Reynolds et al.
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Depression occurs in 30–40% of stroke vic-
tims, and poststroke depression has been im-
plicated as a contributing factor to impaired re-
covery of stroke victims, along with increased
mortality. In the study, nondepressed patients
receiving a placebo were signiﬁcantly more
likely over the course of 12 months to suffer
a major or minor depressive episode than were
those patients administered an SSRI (selective
serotonin reuptake inhibitor) alone (low-dose
escitalopram, 5mg/day) or thosewho received a
course of PST (41). The resultingNNT for this
study was ∼8. Similarly, a recent review of the
literature on depression prevention in patients
treatedwith interferon-alpha for hepatitisChas
indicated that pretreatment with selective sero-
tonin reuptake inhibitors halves the incidence
of depressive episodes during the interferon-
alpha treatment (28).
A recent report from Amsterdam (52)
evaluated indicated prevention in Dutch
primary-care patients above the age of 75. To
determine the efﬁcacy of an indicated stepped-
care prevention program, 170 individuals with
subthreshold symptom levels of depression or
anxiety were followed. Although these individ-
uals did not yet meet the diagnostic criteria for
their respective disorders, they were offered
either a preventive stepped-care program
or usual care. Comprising the intervention
program were four sequential steps, each
of three months duration: watchful waiting,
cognitive behavioral therapy-based bibliother-
apy, PST, and referrals to primary care if the
patient needed antidepressant medication. In
the end, the incidence of major depressive
episodes and anxiety disorders was reduced by
half over a one-year follow-up period. Thus,
∼24% of patients randomly assigned to usual
treatment experienced the onset of major
depressive episodes or of anxiety disorders,
compared with 11% of participants receiving
the stepped-care treatment for depression
prevention. This stepped-care algorithm was
also demonstrated to be cost-effective (51).
Beyond reducing the incidence of major
depressive episodes, however, prevention
also entails protecting older adults from the
IPT: interpersonal
psychotherapy
CBT: cognitive
behavioral therapy
downstream consequences of depression (36).
One critical downstream consequence is
suicide. Evidencing the efﬁcacy of suicide-
prevention strategies is the PROSPECT study
(2, 10) (Prevention of Suicide in Primary Care
Elderly: Collaborative Trial). PROSPECT
showed that by exporting depression care
management strategies to urban and ru-
ral primary-care practices in New York,
Philadelphia, and Pittsburgh, a reduction in
suicidal ideation was observed over 2 years,
from baseline rates of 25–30% to rates at
follow-up of ∼10–15%. Taken together, the
available data, though still limited, suggest the
feasibility, efﬁcacy, and safety of selective and
indicated depression prevention in other adults.
Meta-analytic reviews of studies in HICs
have found that the incidence of new depres-
sive disorders can be reduced by ∼25% over
1–2 years compared with usual care (18, 19)
through the use of learning-based psychothera-
pies [such as interpersonal psychotherapy (IPT)
and cognitive behavioral therapy (CBT)], and
PST administered bymental health profession-
als and (in the case of PST) general medicine
clinicians. A recent study, the MANAS trial
conducted in Goa, India (34), demonstrated
that the use of LHCs, as part of a collabora-
tive stepped-care intervention, signiﬁcantly in-
creased recovery rates from common mental
disorders (anxiety and depression) in patients of
public primary-care facilities. (MANAS means
“project to promote mental health” in the lo-
cal Konkan language.) The MANAS inter-
vention also showed a trendworthy reduction
( p = 0.07) in the incidence of depressive dis-
orders in patients with subthreshold (subsyn-
dromal) depressive symptoms. Given the short-
age of mental health specialists in LMICs,
MANAS utilized the strategy of task shift-
ing, that is, the redistribution of tasks among
health workforce teams, to make more efﬁ-
cient use of lay human resources for health.
Developingmodels of depression prevention in
older adults via lay delivery systems seems es-
pecially salient in LMICs but would also clearly
have implications for practice and policy in
HICs.
www.annualreviews.org • Early Intervention to Reduce Depression 127
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In our review of prevention trials performed
in HICs, we found additional evidence, some
from controlled clinical trials and some from
open studies, that supports both selective and
indicated models of depression prevention in
older adults (16):
1. Social support groups and widow-to-
widow programs for spousally bereaved
individuals (33);
2. Support groups, psychoeducational in-
terventions, respite care and multicom-
ponent interventions aimed at caregivers
of frail older patients and dementia care-
givers (9, 20, 44);
3. Supportive interventions for nursing
home residents (17);
4. PST in older adults with chronic general
medical illnesses, such as macular degen-
eration (42) and stroke (41);
5. Antidepressive medication in high-risk
older adults, such as those who are of
poststroke status (41);
6. Psychoeducational interventions, such as
the Coping with Depression course, a
CBT-based intervention (15);
7. Life review and reminiscence (6);
8. Internet-based CBT (47); and
9. Stepped-care models for older primary-
care adults with subthreshold depression
or anxiety symptoms (51, 52).
With respect to prevention of recurrent
major depression, Reynolds, Dew, Anderson,
and colleagues (37–39) have shown that
maintenance treatment using a variety of
psychosocial (e.g., IPT) and pharmacologic
interventions (tricyclic antidepressants, SSRIs,
and acetylcholinesterase inhibitors) can prevent
depression recurrence (NNTs of 4–5) and slow
cognitive decline and conversion to dementia
in older adults (37–39), in addition to reducing
suicide risk in older primary-care adults (10). In
addition, Buysse, Reynolds, and colleagues (11)
have demonstrated the efﬁcacy of brief behav-
ioral treatment for chronic insomnia (BBTI)
in older primary-care adults (n = 79): with
both a higher response rate of 67% versus 25%
in an information control condition and with
signiﬁcantly greater reduction in symptoms of
depression and anxiety (11). This work suggests
the potential value of treating insomnia as a
means of preventing mental disorders such as
major depression and anxiety (21).
WHAT IS THE POTENTIAL FOR
IMPACT ON GLOBAL MENTAL
HEALTH? EXPERIENCE FROM
INDIA AND THE NETHERLANDS
Of relevance to LMICs, MANAS LHCs
provided psychoeducation to patients who
screened positive for commonmental disorders
and focused on educating the person about their
symptoms aswell as the need to share emotional
symptoms with the doctor and other key people
in their social network (34). LHCs taught pa-
tients strategies to alleviate symptoms, such as
learning breathing exercises for anxiety symp-
toms, scheduling activities for depression symp-
toms, and adhering to medication regimens for
those patients receiving antidepressants. They
also provided information about social and wel-
fare organizations when needed. The MANAS
trial used as a control condition enhanced usual
care, in which physicians and patients received
screening results and were given the treatment
manual prepared for primary-care physicians.
The intervention and control groups comprised
1,360 and 1,436 participants, respectively. On
the basis of intent-to-treat sample completion
rates of 85–88%, the intervention had an im-
pact on 6-month recovery rates from common
mental disorders [65% versus 52.9% (NNT =
8), with a stronger effect in public facility at-
tenders: 65.9% versus 42.5% (NNT = 4)]. In
the subthreshold cases, the study demonstrated
a protective effect of the intervention overall
in terms of 6-month prevalence rates: 5.63%
in collaborative stepped-care versus 7.62% in
enhanced usual care (mean difference −1.90,
p = 0.07). IPT was chosen as the psycholog-
ical treatment because it was effective for ma-
jor depressive disorder in trials in Uganda and
Chile (4, 7). However, a key ﬁnding ofMANAS
was that IPT was not acceptable or feasible in
its original format, and LHCs improvised to
deliver an abbreviated form, comprising only
128 Reynolds et al.
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some components of the initial phases of IPT
combined with psychoeducation delivered over
1–3 sessions.
The use of the Internet to disseminate
depression-prevention strategies is promising
and deserves much more study than it has
received to date (31). An interesting example is
whether improving sleep quality via Internet-
based CBT approaches to chronic insomnia
could lead to reductions in the incidence and/or
severity of common mental disorders (such as
depression and anxiety) and substance use dis-
orders. As illustrated by research and clinical ex-
perience in the Netherlands, several evidence-
based preventive Internet interventions are
available for all Dutch citizens at no or minimal
cost, including one for older adults (47). To
move forward, however, investigation into
Internet-based prevention strategies will bene-
ﬁt from the creationof guidelines for reasonable
expectations for ethical Internet research, for
example, assuring that users know that theWeb
site cannot provide crisis intervention (31).
In the context of public health impact, the
experience of the Netherlands in reaching
the target populations is instructive. The
Netherlands has one of the world’s most
efﬁcient and population-oriented health care
systems; thus, it is not surprising that the
intellectual and health policy leadership for
development and dissemination of depression
prevention has occurred there probably more
than anywhere else in the world. That said, a
relatively small proportion of persons living
with minor depression take advantage of
depression-prevention services offered in the
Netherlands (16).
Possibilities to increase participation rates
include strategies addressed to patients and to
health care and social service organizations.
Strategies aimed at potential participants in
depression-prevention services could and
probably should include media campaigns to
reduce stigma (“promotion” and “universal”
prevention, to use the IOM’s 2009 lexicon),
as well as media campaigns stressing the
possibility of preventing depression. Organi-
zational solutions would probably include the
offering of coping-with-depression courses
through the Internet, further embedding
preventive services in primary care, and further
embedding coping-with-depression courses in
broader community interventions. Inevitably,
approaches such as these will entail efforts
to increase awareness in health professionals
about the availability and efﬁcacy of preventive
services and systematic screening of potential
participants.
RECOMMENDATIONS FOR
DEPRESSION-PREVENTION
RESEARCH
To move the ﬁeld forward and to maximize
appropriate change in clinical practice and
policy, we recommend several strategies:
ﬁrst, use of fewer exclusion criteria to recruit
clinically representative participants with
medical, neurologic, and/or psychosocial risk
factors/comorbidities common in later life;
second, partnerships with primary-care prac-
tices and community-based agencies reaching
low-income adults where public health need is
greatest; third, use of lean assessment batteries
with low respondent burden that are appro-
priate for people with little formal education;
fourth, speciﬁcation of prevention-relevant
outcomes beyond symptom ratings, such as
burden of coexisting medical illness (especially
cardiovascular and cerebrovascular illness),
degree of cognitive and functional impair-
ment, and caregiver burden; ﬁfth, follow-up
periods of at least 12 months and, preferably,
24 months to derive more accurate and clin-
ically meaningful estimates of true incidence
reduction; and sixth, use of a structured but
ﬂexible and culturally appropriate menu of
approaches to be carried out by general medical
clinicians (rather thanmental health specialists)
and/or LHCs. Research projects need to be
powered to detect moderately large effect sizes
of interventions on the cumulative incidence
of major depression over one- and two-year
follow-up periods. On the basis of the limited
published data, this means sample sizes on the
order of 150–300 participants (or 75–150 in
each of the experimental and control arms).
www.annualreviews.org • Early Intervention to Reduce Depression 129
A
nn
u.
 R
ev
. P
ub
lic
. H
ea
lth
. 2
01
2.
33
:1
23
-1
35
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 V
rije
 U
niv
ers
ite
it -
 A
ms
ter
da
m 
- L
ibr
ary
 on
 03
/20
/12
. F
or 
pe
rso
na
l u
se 
on
ly.
PU33CH08-Reynolds ARI 21 February 2012 9:12
General Approach
Because of the diversity of challenges inherent
in risk for depression in later life, interventions
need to allow for some degree of tailoring to
meet the speciﬁc needs of the individual and
his/her caregiver. Thus, a structured but also
tailored approach to delivering the interven-
tions responsive to individual needs is appro-
priate. Important synergies, for example, can
be attained by simultaneously intervening with
the caregiver and with the care recipient. That
is, dyadic intervention may have greater poten-
tial owing to effects on factors such as effective
support seeking and support provision within
the dyad (45).
Interventions that have already been shown
to promote self-efﬁcacy and resilience in prior
studies of depression treatment seem to be
promising candidates. The focus should be on
assessing the value of such strategies before
older adults become ill, in the face of the most
pervasive risk factors for depression in old age:
disabilities related to medical and cognitive im-
pairments, social isolation, caregiving burden,
bereavement, and poor sleep (43, 46).
Promising Interventions
Simple, brief, learning-based approaches,
already shown to have efﬁcacy in the treatment
of depressive disorders, pain, or insomnia dis-
orders, seem promising to address the mandate
of the NIMH Strategic Plan (Strategy 2.3) to
develop and test innovative interventions to
reduce risk and positively alter trajectories of
illness (32). Although antidepressant medica-
tions are the most widely used modality for
treating prevalent cases of major depression,
their use in subthreshold depression may be
ill-advised owing to a lack of evidence for
efﬁcacy in mild depression, as well as adverse
effects, such as hyponatremia, risk for falls,
bone demineralization, and cataracts, in older
adults (22). Psychological interventions may
be preferable for reasons of safety and patient
preference. PST, inwhich behavioral activation
is an important component, has been used in
depression-prevention studies successfully (12,
42, 52), ismore easily utilized than IPTorCBT,
and can be embedded within a clear service
model (5). Teaching coping skills may diminish
the sense of loss of control (feeling trapped or
helpless) at the core of depression. Similarly,
teaching strategies for better sleep (because
poor sleep is a known and well-established risk
factor for depression)may diminish affective re-
activity and enhance cognitive ﬂexibility on the
part of both care recipients and caregivers (11,
23). In this context, BBTI seems particularly
promising because it has been shown to im-
prove sleep quality and reduce symptoms of de-
pression and anxiety (23). Moreover, learning-
based interventions are effective for prevalent
cases of depression and insomnia. Interventions
such as PST and BBTI are also practicable,
i.e., safe, cheap, deliverable by general medical
clinicians (including nurses, social workers,
and potentially LHCs), and more likely to be
acceptable to older adults than would be the
use of antidepressant medication before major
depression is diagnosable. An important caveat
in this discussion, however, is demonstrated
by data showing that SSRI pharmacotherapy is
effective in the prevention of recurrent episode
depression, an enormously important clinical
issue in the care of older adults (38).
Given their very low cost, desirable safety
proﬁle, and general acceptability, the use of nu-
triceuticals also holds promise as an approach to
preventing depression in old age, particularly in
LMICs. In this context, the VITAL-DEP trial
(VITamin D and OmegA-3 TriaL-Depression
Endpoint Prevention, R01-MH091,448),
which is presently getting under way, is poised
to make an important contribution. Led by
Olivia Okereke at Harvard Medical School,
VITAL-DEP is an ancillary study integrated
with VITAL (U01-CA138,962), a National
Institutes of Health–sponsored trial of cancer
and heart-disease prevention. Using long-term
(5-year) vitamin D3 and marine omega-3
fatty-acid supplementation in a 2 × 2 factorial
RCT design among a well-characterized,
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community-dwelling cohort of 10,000 men
(aged ≥60) and 10,000 women (aged ≥65),
VITAL-DEP will estimate these agents’ effects
on depression risk and mood symptoms.
Furthermore, the trial will test the impact of
the agents on depression risk among African
Americans, who will comprise ∼25% of the
study population. Finally, a random subset of
1,000 men and women will be recruited to local
clinical trial centers for detailed, in-person
neuropsychiatric assessments; among these
participants the trial will test effects of the
agents on reducing the risk of depression
among those with high-risk factors (43, 46)
(selective prevention) and of major depression
among those with subsyndromal symptoms
(indicated prevention). Thus, VITAL-DEP
is the ﬁrst randomized trial with scale and
statistical power sufﬁcient to incorporate
universal, selective, and indicated approaches
to late-life depression prevention.
Important Measurement Domains
The literature suggests a core of shared mea-
surement domains in keeping with the gen-
eral logic model articulated here: depression
and anxiety (both categorical measures and
dimensional measures of severity), comorbid
medical burden, social and physical disabil-
ity, insomnia, pain, cognitive status, social iso-
lation/support, caregiver burden, self-efﬁcacy,
problem-solving skills, and promising biopre-
dictors of depression (e.g., proinﬂammatory
cytokines) (28, 48, 49). Biopredictors of depres-
sion may enable depression prevention to focus
on individuals at highest risk and offer guid-
ance about when and where in the pathway to
depression one might best intervene.
Need to Personalize
Depression-Prevention Strategies
Because most older adults do not become
depressed after a disabling medical event or
negative life event such as bereavement, the ef-
ﬁciency of depression-prevention efforts needs
to be further enhanced. To address the ques-
tion of which patients are most likely to beneﬁt
from depression-prevention efforts, it seems
important to investigate both proﬁles of social
worlds and biosignatures of depression risk and
of response to prophylactic interventions (e.g.,
mRNA transciptomes, cytokine activity, sleep).
That is, the ﬁeld should seek to understand
biological correlates of the likelihood of de-
pression, time period of risk, and risk reduction
using psychosocial or biological strategies. This
is in keeping with the general goal of research:
to develop ways of estimating depression risk
(using sociodemographic, clinical, and bio-
logical variables easily obtained in community
settings), based on models of pathogenesis,
to guide the rational, timely, and clinically
appropriate introduction of risk-reduction
strategies to persons who need them most.
As suggested above, an important dimen-
sion of risk for depression and anxiety is poor
sleep (21). Insomnia is known to be a potent
risk factor for depression and anxiety, not
simply a prodrome. What is not yet known is
whether protecting sleep or improving sleep
quality prevents depression in older adults.
Poor sleep is also highly prevalent in later life,
especially among those living with social and
ﬁnancial strain, those living with chronic pain
and related medical disabilities, and those with
mild cognitive impairment and progressive
cognitive disability. Poor sleep in the care re-
cipient also affects caregivers, often leading to a
decision to place a family member in long-term
care. Furthermore, there appears to be a bidi-
rectional relationship between poor sleep and
increase in proinﬂammatory cytokine activity.
Both appear to be depressogenic (29). Thus,
improving sleep ﬁts well into the conceptual
framework of depression prevention articulated
here (23). Good sleep is important to regulating
affect, decreasing stress reactivity, and helping
to mitigate chronic pain. It is also essential to
information processing, cognitive ﬂexibility,
and problem solving. Insomnia is a modiﬁable
precursor and risk factor for depression oc-
currence and reoccurrence. Teaching people
www.annualreviews.org • Early Intervention to Reduce Depression 131
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healthy sleep habits, getting them to under-
stand and experience ﬁrsthand how changing
behavior affects health, is a unique entree into
sustainable, health-promoting life styles. In
this context, we have recently published clinical
trial data showing that curtailing time in bed
and allowing less sleep is associated with poorer
health outcomes in adults 75 and older over
a 30-month period of observation (40). There
appear to be close relationships between sleep
duration/quality, health span, and life span.
Finally, we recommend that depression-
prevention research adhere to the U.K.
Medical Research Council (MRC) guidelines
for developing and evaluating complex inter-
ventions (14). These guidelines underscore
the importance of a good theoretical under-
standing of how interventions cause change (or
protect, in the case of prevention) so that weak
links in the causal chain of pathogenesis can
be identiﬁed and strengthened. In addition,
MRC guidelines emphasize that lack of effect
may reﬂect implementation failure rather than
genuine ineffectiveness, hence the need for a
thorough evaluation process to identify im-
plementation problems. Finally, the guidelines
emphasize the importance of adequate sample
sizes to take account of variability in outcome,
a range of outcomes to optimize data use, and
adaptation to local settings.
SUMMARY POINTS
1. The number of older adults in LMICs, including India andChina, will grow substantially
in the next few decades. According to the U.S. Census National Database (50), the age
60+ population in India is ∼99.4 million persons in 2011 (9%). The projections for
2030 are 192.7 million (14.3%). In China, the comparable numbers are 178 million
(13%) and 350 million (25%) in 2011 and 2030, respectively. There is thus an urgency
to develop innovative and cost-effective interventions to meet the need for mental health
care delivery in older adults.
2. Major depressive episodes in older adults are prevalent and disabling (6–10% in primary-
care settings; 30% in inpatient medical and long-term care settings). Incidence rates are
about half of prevalence rates (36).
3. The disorder often runs a relapsing or chronic course, and social factors, particularly
related to economic or social disadvantages such as low education and violence, are
major determinants (13, 38, 39).
4. The condition is often comorbid with other chronic conditions such as diabetes and is
responsible for much of the disability associated with these conditions (10, 30, 43).
5. Depression is associated with worse physical health, for example, cardiovascular or HIV
outcomes, by undermining treatment adherence and healthy lifestyle choices (10).
6. Depression is associated with excess mortality after myocardial infarction, stroke, and
cancer diagnosis and is the major risk factor for suicide in old age (36).
7. Available pharmacologic and psychosocial treatments are only partially satisfactory in
reducing symptom burden, sustaining remission, and averting years lived with disability;
hence, effective preventive interventions are needed (5, 16).
8. The treatment gap for people with mental disorders has been extensively documented,
especially in LMICs, where close to 90% of people with mental disorders do not receive
cost-effective treatments (34).
132 Reynolds et al.
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9. The great scarcity of mental health specialists in most countries and the inequity of the
distribution in these specialists are major barriers to closing the treatment gap (20, 26,
34). The existence of the treatment gap and the attendantworkforce issues underscore the
need for developing effective models of depression prevention that can be implemented
by health workers with shorter training and fewer qualiﬁcations to make more efﬁcient
use of the available human resources for health (3, 35).
10. Preventing depression in older adults may be cost-effective (46, 51) by preventing the
downward spiral of depression→disability→death andprolongingolder adults’ capacity
for independence.
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